|
1
|
Chen X, Comish PB, Tang D and Kang R:
Characteristics and biomarkers of ferroptosis. Front Cell Dev Biol.
9:6371622021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang H and Xie Y: Advances in ferroptosis
research: A comprehensive review of mechanism exploration, drug
development, and disease treatment. Pharmaceuticals (Basel).
18:3342025. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ma W, Jiang X, Jia R and Li Y: Mechanisms
of ferroptosis and targeted therapeutic approaches in urological
malignancies. Cell Death Discov. 10:4322024. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yan HF, Zou T, Tuo QZ, Xu S, Li H, Belaidi
AA and Lei P: Ferroptosis: Mechanisms and links with diseases.
Signal Transduct Target Ther. 6:492021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zheng J and Conrad M: Ferroptosis: When
metabolism meets cell death. Physiol Rev. 105:651–706. 2025.
View Article : Google Scholar
|
|
6
|
Huang X: A concise review on oxidative
stress-mediated ferroptosis and cuproptosis in Alzheimer's disease.
Cells. 12:13692023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Naderi S, Khodagholi F, Janahmadi M,
Motamedi F, Torabi A, Batool Z, Heydarabadi MF and Pourbadie HG:
Ferroptosis and cognitive impairment: Unraveling the link and
potential therapeutic targets. Neuropharmacology. 263:1102102025.
View Article : Google Scholar
|
|
8
|
Zhang Y, Wang Y, Li Y, Pang J, Höhn A,
Dong W, Gao R, Liu Y, Wang D, She Y, et al: Methionine restriction
alleviates Diabetes-associated cognitive impairment via activation
of FGF21. Redox Biol. 77:1033902024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ryan SK, Ugalde CL, Rolland AS, Skidmore
J, Devos D and Hammond TR: Therapeutic inhibition of ferroptosis in
neurodegenerative disease. Trends Pharmacol Sci. 44:674–688. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Khan G, Hussain MS, Khan Y, Fatima R,
Ahmad S, Sultana A and Alam P: Ferroptosis and its contribution to
cognitive impairment in Alzheimer's disease: Mechanisms and
therapeutic potential. Brain Res. 1864:1497762025. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma M, Jing G, Tian Y, Yin R and Zhang M:
Ferroptosis in cognitive impairment associated with diabetes and
Alzheimer's disease: Mechanistic insights and new therapeutic
opportunities. Mol Neurobiol. 62:2435–2449. 2025. View Article : Google Scholar
|
|
12
|
Jacquemyn J, Ralhan I and Ioannou MS:
Driving factors of neuronal ferroptosis. Trends Cell Biol.
34:535–546. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yan N and Zhang JJ: The emerging roles of
ferroptosis in vascular cognitive impairment. Front Neurosci.
13:8112019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Y, Li Z, Ran Q and Wang P: Sterols in
ferroptosis: From molecular mechanisms to therapeutic strategies.
Trends Mol Med. 31:36–49. 2025. View Article : Google Scholar
|
|
15
|
Li QS and Jia YJ: Ferroptosis: A critical
player and potential therapeutic target in traumatic brain injury
and spinal cord injury. Neural Regen Res. 18:506–512. 2023.
View Article : Google Scholar
|
|
16
|
Shui S, Zhao Z, Wang H, Conrad M and Liu
G: Non-enzymatic lipid peroxidation initiated by photodynamic
therapy drives a distinct ferroptosis-like cell death pathway.
Redox Biol. 45:1020562021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang S, Zhang M, Liu C, Li M, Lou Y and
Tan H: Redox mechanism of glycerophospholipids and relevant
targeted therapy in ferroptosis. Cell Death Discov. 11:3582025.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fei W, Chen D, Tang H, Li C, Zheng W, Chen
F, Song Q, Zhao Y, Zou Y and Zheng C: Targeted GSH-exhausting and
hydroxyl radical self-producing manganese-silica nanomissiles for
MRI guided ferroptotic cancer therapy. Nanoscale. 12:16738–16754.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee J and Hyun DH: The interplay between
intracellular iron homeostasis and neuroinflammation in
neurodegenerative diseases. Antioxidants (Basel). 12:9182023.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang XD, Liu ZY, Wang MS, Guo YX, Wang
XK, Luo K, Huang S and Li RF: Mechanisms and regulations of
ferroptosis. Front Immunol. 14:12694512023. View Article : Google Scholar :
|
|
21
|
Kakhlon O and Cabantchik ZI: The labile
iron pool: Characterization, measurement, and participation in
cellular processes(1). Free Radic Biol Med. 33:1037–1046. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Arosio P, Elia L and Poli M: Ferritin,
cellular iron storage and regulation. IUBMB Life. 69:414–422. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mancias JD, Wang X, Gygi SP, Harper JW and
Kimmelman AC: Quantitative proteomics identifies NCOA4 as the cargo
receptor mediating ferritinophagy. Nature. 509:105–109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mancias JD, Pontano Vaites L, Nissim S,
Biancur DE, Kim AJ, Wang X, Liu Y, Goessling W, Kimmelman AC and
Harper JW: Ferritinophagy via NCOA4 is required for erythropoiesis
and is regulated by iron dependent HERC2-mediated proteolysis.
Elife. 4:e103082015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ajoolabady A, Aslkhodapasandhokmabad H,
Libby P, Tuomilehto J, Lip GYH, Penninger JM, Richardson DR, Tang
D, Zhou H, Wang S, et al: Ferritinophagy and ferroptosis in the
management of metabolic diseases. Trends Endocrinol Metab.
32:444–462. 2021. View Article : Google Scholar
|
|
26
|
Forcina GC and Dixon SJ: GPX4 at the
crossroads of lipid homeostasis and ferroptosis. Proteomics.
19:e18003112019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bridges RJ, Natale NR and Patel SA: System
xc− Cystine/glutamate antiporter: An update on molecular
pharmacology and roles within the CNS. Br J Pharmacol. 165:20–34.
2012. View Article : Google Scholar :
|
|
28
|
Conrad M and Sato H: The oxidative
stress-inducible cystine/glutamate antiporter, system x (c) (-):
Cystine supplier and beyond. Amino Acids. 42:231–246. 2012.
View Article : Google Scholar
|
|
29
|
Xue Z, Nuerrula Y, Sitiwaerdi Y and Eli M:
Nuclear factor erythroid 2-related factor 2 promotes
radioresistance by regulating glutamate-cysteine ligase modifier
subunit and its unique immunoinvasive pattern. Biomol Biomed.
24:545–559. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ursini F and Maiorino M: Lipid
peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic
Biol Med. 152:175–185. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang WS, SriRamaratnam R, Welsch ME,
Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji
AF, Clish CB and Brown LM: Regulation of ferroptotic cancer cell
death by GPX4. Cell. 156:317–331. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Benarroch E: What is the role of
ferroptosis in neurodegeneration? Neurology. 101:312–319. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou M, Xu K, Ge J, Luo X, Wu M, Wang N
and Zeng J: Targeting ferroptosis in Parkinson's disease:
Mechanisms and emerging therapeutic strategies. Int J Mol Sci.
25:130422024. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kraft VAN, Bezjian CT, Pfeiffer S,
Ringelstetter L, Müller C, Zandkarimi F, Merl-Pham J, Bao X,
Anastasov N, Kössl J, et al: GTP cyclohydrolase
1/tetrahydrobiopterin counteract ferroptosis through lipid
remodeling. ACS Cent Sci. 6:41–53. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Soula M, Weber RA, Zilka O, Alwaseem H, La
K, Yen F, Molina H, Garcia-Bermudez J, Pratt DA, Birsoy K, et al:
Metabolic determinants of cancer cell sensitivity to canonical
ferroptosis inducers. Nat Chem Biol. 16:1351–1360. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee
H, Koppula P, Wu S, Zhuang L, Fang B, et al: DHODH-mediated
ferroptosis defence is a targetable vulnerability in cancer.
Nature. 593:586–590. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Teng D, Swanson KD, Wang R, Zhuang A, Wu
H, Niu Z, Cai L, Avritt FR, Gu L, Asara JM, et al: DHODH modulates
immune evasion of cancer cells via CDP-choline dependent regulation
of phospholipid metabolism and ferroptosis. Nat Commun.
16:38672025. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cao J, Chen X, Chen L, Lu Y, Wu Y, Deng A,
Pan F, Huang H, Liu Y, Li Y, et al: DHODH-mediated mitochondrial
redox homeostasis: A novel ferroptosis regulator and promising
therapeutic target. Redox Biol. 85:1037882025. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li Z, Chen X, Xiang W, Tang T and Gan L:
m6A demethylase FTO-mediated upregulation of BAP1 induces neuronal
ferroptosis via the p53/SLC7A11 axis in the MPP+/MPTP-induced
Parkinson's disease model. ACS Chem Neurosci. 16:405–416. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tarangelo A, Magtanong L, Bieging-Rolett
KT, Li Y, Ye J, Attardi LD and Dixon SJ: p53 suppresses metabolic
stress-induced ferroptosis in cancer cells. Cell Rep. 22:569–575.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jiang M, Qiao M, Zhao C, Deng J, Li X and
Zhou C: Targeting ferroptosis for cancer therapy: Exploring novel
strategies from its mechanisms and role in cancers. Transl Lung
Cancer Res. 9:1569–1584. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lewerenz J, Hewett SJ, Huang Y, Lambros M,
Gout PW, Kalivas PW, Massie A, Smolders I, Methner A, Pergande M,
et al: The cystine/glutamate antiporter system x(c)(-) in health
and disease: From molecular mechanisms to novel therapeutic
opportunities. Antioxid Redox Signal. 18:522–555. 2013. View Article : Google Scholar :
|
|
43
|
Sun Y, Xiao Y, Tang Q, Chen W and Lin L:
Genetic markers associated with ferroptosis in Alzheimer's disease.
Front Aging Neurosci. 16:13646052024. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Streit WJ, Phan L and Bechmann I:
Ferroptosis and pathogenesis of neuritic plaques in Alzheimer
disease. Pharmacol Rev. 77:1000052025. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Proneth B and Conrad M: Ferroptosis and
necroinflammation, a yet poorly explored link. Cell Death Differ.
26:14–24. 2019. View Article : Google Scholar
|
|
46
|
McIntosh A, Mela V, Harty C, Minogue AM,
Costello DA, Kerskens C and Lynch MA: Iron accumulation in
microglia triggers a cascade of events that leads to altered
metabolism and compromised function in APP/PS1 mice. Brain Pathol.
29:606–621. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhao H, Wang J, Li Z, Wang S, Yu G and
Wang L: Identification Ferroptosis-related hub genes and diagnostic
model in Alzheimer's disease. Front Mol Neurosci. 16:12806392023.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tian M, Shen J, Qi Z, Feng Y and Fang P:
Bioinformatics analysis and prediction of Alzheimer's disease and
alcohol dependence based on Ferroptosis-related genes. Front Aging
Neurosci. 15:12011422023. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang Y, Wang M and Chang W: Iron
dyshomeostasis and ferroptosis in Alzheimer's disease: Molecular
mechanisms of cell death and novel therapeutic drugs and targets
for AD. Front Pharmacol. 13:9836232022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sun J, Lin XM, Lu DH, Wang M, Li K, Li SR,
Li ZQ, Zhu CJ, Zhang ZM, Yan CY, et al: Midbrain dopamine oxidation
links ubiquitination of glutathione peroxidase 4 to ferroptosis of
dopaminergic neurons. J Clin Invest. 133:e1731102023. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zheng Z, Zhang S, Liu X, Wang X, Xue C, Wu
X, Zhang X, Xu X, Liu Z, Yao L and Lu G: LRRK2 regulates
ferroptosis through the system xc-GSH-GPX4 pathway in the
neuroinflammatory mechanism of Parkinson's disease. J Cell Physiol.
239:e312502024. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Negida A, Hassan NM, Aboeldahab H, Zain
YE, Negida Y, Cadri S, Cadri N, Cloud LJ, Barrett MJ and Berman B:
Efficacy of the Iron-chelating agent, deferiprone, in patients with
Parkinson's disease: A systematic review and Meta-analysis. CNS
Neurosci Ther. 30:e146072024. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Angelova PR, Choi ML, Berezhnov AV,
Horrocks MH, Hughes CD, De S, Rodrigues M, Yapom R, Little D, Dolt
KS, et al: Alpha synuclein aggregation drives ferroptosis: An
Interplay of iron, calcium and lipid peroxidation. Cell Death
Differ. 27:2781–2796. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wang H, Wu S, Li Q, Sun H and Wang Y:
Targeting ferroptosis: Acteoside as a neuroprotective agent in
salsolinol-induced Parkinson's disease models. Front Biosci
(Landmark Ed). 30:266792025. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yan J, Bao L, Liang H, Zhao L, Liu M, Kong
L, Fan X, Liang C, Liu T, Han X, et al: A druglike ferrostatin-1
analogue as a ferroptosis inhibitor and photoluminescent indicator.
Angew Chem Int Ed Engl. 64:e2025021952025. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
A A, W C, N N, L M, M D and Zhang DD:
α-Syn overexpression, NRF2 suppression, and enhanced ferroptosis
create a vicious cycle of neuronal loss in Parkinson's disease.
Free Radic Biol Med. 192:130–140. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Gong K, Zhou S, Xiao L, Xu M, Zhou Y, Lu
K, Yu X, Zhu J, Liu C and Zhu Q: Danggui shaoyao san ameliorates
Alzheimer's disease by regulating lipid metabolism and inhibiting
neuronal ferroptosis through the AMPK/Sp1/ACSL4 signaling pathway.
Front Pharmacol. 16:15883752025. View Article : Google Scholar
|
|
58
|
Lv QK, Tao KX, Yao XY, Pang MZ, Cao BE,
Liu CF and Wang F: Melatonin MT1 receptors regulate the
Sirt1/Nrf2/ho-1/Gpx4 pathway to prevent α-synuclein-induced
ferroptosis in Parkinson's disease. J Pineal Res. 76:e129482024.
View Article : Google Scholar
|
|
59
|
Wang W, Thomas ER, Xiao R, Chen T, Guo Q,
Liu K, Yang Y and Li X: Targeting mitochondria-regulated
ferroptosis: A new frontier in Parkinson's disease therapy.
Neuropharmacology. 274:1104392025. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang Q, Liu J, Zhang Y, Li Z, Zhao Z,
Jiang W, Zhao J, Hou L and Wang Q: Microglial CR3 promotes neuron
ferroptosis via NOX2-mediated iron deposition in rotenone-induced
experimental models of Parkinson's disease. Redox Biol.
77:1033692024. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wang H, Mao W, Zhang Y, Feng W, Bai B, Ji
B, Chen J, Cheng B and Yan F: NOX1 triggers ferroptosis and
ferritinophagy, contributes to Parkinson's disease. Free Radic Biol
Med. 222:331–343. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Lin Z, Ying C, Si X, Xue N, Liu Y, Zheng
R, Chen Y, Pu J and Zhang B: NOX4 exacerbates Parkinson's disease
pathology by promoting neuronal ferroptosis and neuroinflammation.
Neural Regen Res. 20:2038–2052. 2025. View Article : Google Scholar
|
|
63
|
Xie Z, Wang X, Luo X, Yan J, Zhang J, Sun
R, Luo A and Li S: Activated AMPK mitigates Diabetes-related
cognitive dysfunction by inhibiting hippocampal ferroptosis.
Biochem Pharmacol. 207:1153742023. View Article : Google Scholar
|
|
64
|
Wei M, Liu X, Tan Z, Tian X, Li M and Wei
J: Ferroptosis: A new strategy for Chinese herbal medicine
treatment of diabetic nephropathy. Front Endocrinol (Lausanne).
14:11880032023. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Sha W, Hu F, Xi Y, Chu Y and Bu S:
Mechanism of ferroptosis and its role in type 2 diabetes mellitus.
J Diabetes Res. 2021:99996122021. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Liu J, Hu X, Xue Y, Liu C, Liu D, Shang Y,
Shi Y, Cheng L, Zhang J, Chen A and Wang J: Targeting hepcidin
improves cognitive impairment and reduces iron deposition in a
diabetic rat model. Am J Transl Res. 12:4830–4839. 2020.PubMed/NCBI
|
|
67
|
Tang W, Li Y, He S, Jiang T, Wang N, Du M,
Cheng B, Gao W, Li Y and Wang Q: Caveolin-1 alleviates
diabetes-associated cognitive dysfunction through modulating
neuronal ferroptosis-mediated mitochondrial homeostasis. Antioxid
Redox Signal. 37:867–886. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Guo T, Yu Y, Yan W, Zhang M, Yi X, Liu N,
Cui X, Wei X, Sun Y, Wang Z, et al: Erythropoietin ameliorates
cognitive dysfunction in mice with type 2 diabetes mellitus via
inhibiting iron overload and ferroptosis. Exp Neurol.
365:1144142023. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhao Y, Guo H and Li Q, Wang N, Yan C,
Zhang S, Dong Y, Liu C, Gao W, Zhu Y and Li Q: TREM1 induces
microglial ferroptosis through the PERK pathway in
diabetic-associated cognitive impairment. Exp Neurol.
383:1150312025. View Article : Google Scholar
|
|
70
|
Ma H, Jiang T, Tang W, Ma Z, Pu K, Xu F,
Chang H, Zhao G, Gao W, Li Y and Wang Q: Transplantation of
platelet-derived mitochondria alleviates cognitive impairment and
mitochondrial dysfunction in db/db mice. Clin Sci (Lond).
134:2161–2175. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Asterholm IW, Mundy DI, Weng J, Anderson
RGW and Scherer PE: Altered mitochondrial function and metabolic
inflexibility associated with loss of caveolin-1. Cell Metab.
15:171–185. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Feng Q, Yang Y, Qiao Y, Zheng Y, Yu X, Liu
F, Wang H, Zheng B, Pan S, Ren K, et al: Quercetin ameliorates
diabetic kidney injury by inhibiting ferroptosis via activating
Nrf2/HO-1 signaling pathway. Am J Chin Med. 51:997–1018. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Li J, Cao Y, Xu J, Li J, Lv C, Gao Q,
Zhang C, Jin C, Wang R, Jiao R and Zhu H: Vitamin D improves
cognitive impairment and alleviates ferroptosis via the Nrf2
signaling pathway in aging mice. Int J Mol Sci. 24:153152023.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Wei Z, Yu H, Zhao H, Wei M, Xing H, Pei J,
Yang Y and Ren K: Broadening horizons: Ferroptosis as a new target
for traumatic brain injury. Burns Trauma. 12:tkad0512024.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Abdukarimov N, Kokabi K and Kunz J:
Ferroptosis and iron homeostasis: Molecular mechanisms and
neurodegenerative disease implications. Antioxidants (Basel).
14:5272025. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Wang B, Fu C, Wei Y, Xu B, Yang R, Li C,
Qiu M, Yin Y and Qin D: Ferroptosis-related biomarkers for
alzheimer's disease: Identification by bioinformatic analysis in
hippocampus. Front Cell Neurosci. 16:10239472022. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Ficiarà E, Munir Z, Boschi S, Caligiuri ME
and Guiot C: Alteration of iron concentration in Alzheimer's
disease as a possible diagnostic biomarker unveiling ferroptosis.
Int J Mol Sci. 22:44792021. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Ayton S, Faux NG and Bush AI; Alzheimer's
disease neuroimaging initiative: Ferritin levels in the
cerebrospinal fluid predict Alzheimer's disease outcomes and are
regulated by APOE. Nat Commun. 6:67602015. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Urbano T, Michalke B, Chiari A, Malagoli
C, Bedin R, Tondelli M, Vinceti M and Filippini T: Iron species in
cerebrospinal fluid and dementia risk in subjects with mild
cognitive impairment: A cohort study. Neurotoxicology. 110:1–9.
2025. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Urbano T, Vinceti M, Carbone C, Wise LA,
Malavolti M, Tondelli M, Bedin R, Vinceti G, Marti A, Chiari A, et
al: Exposure to cadmium and other trace elements among individuals
with mild cognitive impairment. Toxics. 12:9332024. View Article : Google Scholar :
|
|
81
|
Ayton S, Janelidze S, Kalinowski P,
Palmqvist S, Belaidi AA, Stomrud E, Roberts A, Roberts B, Hansson O
and Bush AI: CSF ferritin in the clinicopathological progression of
Alzheimer's disease and associations with APOE and inflammation
biomarkers. J Neurol Neurosurg Psychiatry. 94:211–219. 2023.
View Article : Google Scholar
|
|
82
|
Yu SY, Cao CJ, Zuo LJ, Chen ZJ, Lian TH,
Wang F, Hu Y, Piao YS, Li LX, Guo P, et al: Clinical features and
dysfunctions of iron metabolism in Parkinson disease patients with
hyper echogenicity in Substantia nigra: A Cross-sectional study.
BMC Neurol. 18:92018. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Padurariu M, Ciobica A, Hritcu L, Stoica
B, Bild W and Stefanescu C: Changes of some oxidative stress
markers in the serum of patients with mild cognitive impairment and
Alzheimer's disease. Neurosci Lett. 469:6–10. 2010. View Article : Google Scholar
|
|
84
|
Lin Q, Shahid S, Hone-Blanchet A, Huang S,
Wu J, Bisht A, Loring D, Goldstein F, Levey A, Crosson B, et al:
Magnetic resonance evidence of increased iron content in
subcortical brain regions in asymptomatic Alzheimer's disease. Hum
Brain Mapp. 44:3072–3083. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Dusek P, Hofer T, Alexander J, Roos PM and
Aaseth JO: Cerebral iron deposition in neurodegeneration.
Biomolecules. 12:7142022. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Majerníková N, Marmolejo-Garza A, Salinas
CS, Luu MDA, Zhang Y, Trombetta-Lima M, Tomin T, Birner-Gruenberger
R, Lehtonen Š, Koistinaho J, et al: The link between amyloid β and
ferroptosis pathway in Alzheimer's disease progression. Cell Death
Dis. 15:7822024. View Article : Google Scholar
|
|
87
|
Kang JH, Korecka M, Lee EB, Cousins KAQ,
Tropea TF, Chen-Plotkin AA, Irwin DJ, Wolk D, Brylska M, Wan Y and
Shaw LM: Alzheimer disease biomarkers: Moving from CSF to plasma
for reliable detection of amyloid and tau pathology. Clin Chem.
69:1247–1259. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Hampel H, O'Bryant SE, Molinuevo JL,
Zetterberg H, Masters CL, Lista S, Kiddle SJ, Batrla R and Blennow
K: Blood-based biomarkers for Alzheimer disease: Mapping the road
to the clinic. Nat Rev Neurol. 14:639–652. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Livingston G, Huntley J, Sommerlad A, Ames
D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J,
Cooper C, et al: Dementia prevention, intervention, and care: 2020
report of the lancet commission. Lancet. 396:413–446. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Biessels GJ and Despa F: Cognitive decline
and dementia in diabetes mellitus: Mechanisms and clinical
implications. Nat Rev Endocrinol. 14:591–604. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Andrews SJ, Tolosa-Tort P, Jonson C,
Fulton-Howard B, Renton AE, Yokoyama JS and Yaffe K; Alzheimer's
Disease Neuroimaging Initiative: The role of genomic-informed risk
assessments in predicting dementia outcomes. Alzheimers Dement.
21:e708262025. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Nasreddine ZS, Phillips NA, Bédirian V,
Charbonneau S, Whitehead V, Collin I, Cummings JL and Chertkow H:
The Montreal cognitive assessment, MoCA: A brief screening tool for
mild cognitive impairment. J Am Geriatr Soc. 53:695–699. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Folstein MF, Folstein SE and McHugh PR:
'Mini-mental state'. A practical method for grading the cognitive
state of patients for the clinician J Psychiatr Res. 12:189–198.
1975.
|
|
94
|
Cullis JO, Fitzsimons EJ, Griffiths WJ,
Tsochatzis E and Thomas DW; British Society for Haematology:
Investigation and management of a raised serum ferritin. Br J
Haematol. 181:331–340. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Stockwell BR, Friedmann Angeli JP, Bayir
H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK,
Kagan VE, et al: Ferroptosis: A regulated cell death nexus linking
metabolism, redox biology, and disease. Cell. 171:273–285. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Wang Y and Liu T: Quantitative
susceptibility mapping (QSM): Decoding MRI data for a tissue
magnetic biomarker. Magn Reson Med. 73:82–101. 2015. View Article : Google Scholar :
|
|
97
|
Jack CR, Bennett DA, Blennow K, Carrillo
MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F,
Karlawish J, et al: NIA-AA research framework: Toward a biological
definition of Alzheimer's disease. Alzheimers Dement. 14:535–562.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Chen HJ, Dong X, Wang Y, Wang K, Feng G,
Bai T, Zhang M, Gan K, Peng JJ, Huang W, et al: Polygenic risk for
Alzheimer's disease in healthy aging: Age-related and APOE-driven
effects on brain structures and cognition. Genome Med. 17:1262025.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Liu Y, Chen M, Chen P, Lin X, Chen S, Liu
C, Wang D, Deng H, Li Q and Wu Y: Machine learning-based
stratification of mild cognitive impairment in Parkinson's disease:
A multicenter cross-sectional analysis. BMC Med Inform Decis Mak.
25:3842025. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Ren Q, Niu S, Zhi L and Liu H: Risk factor
analysis of cognitive frailty in older adults with type 2 diabetes
mellitus: A cross-sectional study. Front Aging Neurosci.
17:16674052025. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Hambright WS, Fonseca RS, Chen L, Na R and
Ran Q: Ablation of ferroptosis regulator glutathione peroxidase 4
in forebrain neurons promotes cognitive impairment and
neurodegeneration. Redox Biol. 12:8–17. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Masaldan S, Bush AI, Devos D, Rolland AS
and Moreau C: Striking while the iron is hot: Iron metabolism and
ferroptosis in neurodegeneration. Free Radic Biol Med. 133:221–233.
2019. View Article : Google Scholar
|
|
103
|
Thorwald MA, Godoy-Lugo JA, Kerstiens E,
Garcia G, Kim M, Shemtov SJ, Silva J, Durra S, O'Day PA, Mack WJ,
et al: Down syndrome with Alzheimer's disease brains have increased
iron and associated lipid peroxidation consistent with ferroptosis.
Alzheimers Dement. 21:e703222025. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Ra F and K H: Oxidative stress in brain
aging. Implications for therapeutics of neurodegenerative diseases.
Neurobiol Aging. 23:795–807. 2002. View Article : Google Scholar
|
|
105
|
Ji Y, Zheng K, Li S, Ren C, Shen Y, Tian
L, Zhu H, Zhou Z and Jiang Y: Insight into the potential role of
ferroptosis in neurodegenerative diseases. Front Cell Neurosci.
16:10051822022. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Tian Y, Tian Y, Yuan Z, Zeng Y, Wang S,
Fan X, Yang D and Yang M: Iron metabolism in aging and age-related
diseases. Int J Mol Sci. 23:36122022. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Baier MP, Sharum SI, Wilson JL, Narasimhan
S, Salim C and Logan S: Enhancing mitochondrial matrix antioxidant
SOD2 in astrocytes mitigates cellular senescence and cognitive
impairment in aging. Aging Dis. Oct 9–2025.Epub ahead of print.
PubMed/NCBI
|
|
108
|
Lu Q, Shao N, Fang Z, Ouyang Z, Shen Y,
Yang R, Liu H, Cai B and Wei T: The anti-Alzheimer's disease
effects of ganoderic acid a by inhibiting Ferroptosis-lipid
peroxidation via activation of the NRF2/SLC7A11/GPX4 signaling
pathway. Chem Biol Interact. 412:1114592025. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Wang M, Li M, Jiang Y, Wang S, Yang X,
Naseem A, Algradi AM, Hao Z, Guan W, Chen Q, et al: Saponins from
Astragalus membranaceus(Fisch.) Bge alleviated neuronal ferroptosis
in Alzheimer's disease by regulating the NOX4/Nrf2 signaling
pathway. J Agric Food Chem. 73:7725–7740. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Meng X, Zhao W, Yang R, Xu SQ, Wang SY, Li
MM, Jiang YK, Hao ZC, Guan W, Kuang HX, et al: Lignans from
Schisandra chinensis(Turcz.) Baill ameliorates cognitive impairment
in Alzheimer's disease and alleviates ferroptosis by activating the
Nrf2/FPN1 signaling pathway and regulating iron levels. J
Ethnopharmacol. 341:1193352025. View Article : Google Scholar
|
|
111
|
Li Z, Lu Y, Zhen Y, Jin W, Ma X, Yuan Z,
Liu B, Zhou XL and Zhang L: Avicularin inhibits ferroptosis and
improves cognitive impairments in Alzheimer's disease by modulating
the NOX4/Nrf2 axis. Phytomedicine. 135:1562092024. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Deng PX, Silva M, Yang N, Wang Q, Meng X,
Ye KQ, Gao HC and Zheng WH: Artemisinin inhibits neuronal
ferroptosis in Alzheimer's disease models by targeting KEAP1. Acta
Pharmacol Sin. 46:326–337. 2025. View Article : Google Scholar
|
|
113
|
Yong Y, Yan L, Wei J, Feng C, Yu L, Wu J,
Guo M, Fan D, Yu C, Qin D, et al: A novel ferroptosis inhibitor,
thonningianin a, improves Alzheimer's disease by activating GPX4.
Theranostics. 14:6161–6184. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Wu Y, Wei M, Wang M, Guo M, Yu H, Chen Y,
Xu T and Zhou Y: Schisandra total lignans ameliorate neuronal
ferroptosis in 3xTg-AD mice via regulating NADK/NADPH/GSH pathway.
Phytomedicine. 140:1566122025. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Ding T, Song M, Wu Y, Li Z, Zhang S and
Fan X: Schisandrin B ameliorates Alzheimer's disease by suppressing
neuronal ferroptosis and ensuing microglia M1 polarization.
Phytomedicine. 142:1567802025. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Zhang ZH, Chen C, Jia SZ, Cao XC, Liu M,
Tian J, Hoffmann PR, Xu HX, Ni JZ and Song GL: Selenium restores
synaptic deficits by modulating NMDA receptors and selenoprotein K
in an Alzheimer's disease model. Antioxid Redox Signal. 35:863–884.
2021. View Article : Google Scholar
|
|
117
|
Zeng H and Jin Z: The role of ferroptosis
in Alzheimer's disease: Mechanisms and therapeutic potential
(review). Mol Med Rep. 32:1922025. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Wang J, Wang Z, Li Y, Hou Y, Yin C, Yang
E, Liao Z, Fan C, Martin LL and Sun D: Blood brain Barrier-targeted
delivery of double selenium nanospheres ameliorates neural
ferroptosis in Alzheimer's disease. Biomaterials. 302:1223592023.
View Article : Google Scholar
|
|
119
|
Sun C, Gao X, Sha S, Wang S, Shan Y, Li L,
Xing C, Guan H and Du H: Berberine alleviates Alzheimer's disease
by activating autophagy and inhibiting ferroptosis through the
JNK-p38MAPK signaling pathway. Int Immunopharmacol. 155:1145502025.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Song D, Gui F, Li G, Zhuang S, Sun J, Tan
X, Hong C and Huang J: Neuritin improves cognitive impairments in
APP/PS1 Alzheimer's disease mice model by mitigating neuronal
ferroptosis via PI3K/Akt activation. Int J Biol Macromol.
303:1406622025. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Guo Y, Zhao J, Liu X, Lu P, Liang F, Wang
X, Wu J and Hai Y: Ghrelin induces ferroptosis resistance and M2
polarization of microglia to alleviate neuroinflammation and
cognitive impairment in Alzheimer's disease. J Neuroimmune
Pharmacol. 20:62025. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Tan L, Xie J, Liao C, Li X, Zhang W, Cai
C, Cheng L and Wang X: Tetrahedral framework nucleic acids inhibit
aβ-mediated ferroptosis and ameliorate cognitive and synaptic
impairments in Alzheimer's disease. J Nanobiotechnology.
22:6822024. View Article : Google Scholar
|
|
123
|
Lei L, Yuan J, Dai Z, Xiang S, Tu Q, Cui
X, Zhai S, Chen X, He Z, Fang B, et al: Targeting the labile iron
pool with engineered DFO nanosheets to inhibit ferroptosis for
Parkinson's disease therapy. Adv Mater. 36:e24093292024. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Ko CJ, Gao SL, Lin TK, Chu PY and Lin HY:
Ferroptosis as a major factor and therapeutic target for
neuroinflammation in Parkinson's disease. Biomedicines. 9:16792021.
View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Han Z, Wang B, Wen YQ, Li YN, Feng CX,
Ding XS, Shen Y, Yang Q and Gao L: Acteoside alleviates lipid
peroxidation by enhancing Nrf2-mediated mitophagy to inhibit
ferroptosis for neuroprotection in Parkinson's disease. Free Radic
Biol Med. 223:493–505. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Kong L, Wang Y, Tong Z, Dai R, Yusuf A, Du
L, Liu B, Huang Z and Hu L: Granulathiazole a protects
6-OHDA-induced Parkinson's disease from ferroptosis via activating
Nrf2/HO-1 pathway. Bioorg Chem. 147:1073992024. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Pandey SK, Nanda A, Gautam AS and Singh
RK: Betulinic acid protects against lipopolysaccharide and ferrous
sulfate-induced oxidative stress, ferroptosis, apoptosis, and
neuroinflammation signaling relevant to Parkinson's disease. Free
Radic Biol Med. 233:340–354. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Fu G, Li T, Zhao Y, Zhang S, Xue X, Yang
Y, Li T, Luo S, Yue G and Lei T: Dingzhen pills inhibit neuronal
ferroptosis and neuroinflammation by inhibiting the cGAS-STING
pathway for Parkinson's disease mice. Chin Med. 20:872025.
View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Dong X, Yang T and Jin Z: Lactobacillus
Reuteri-derived γ-amino butyric acid alleviates MPTP-induced
Parkinson's disease through inhibiting Ferroptosis via the
AKT-GSK3β-GPX4 axis. NPJ Parkinsons Dis. 11:1492025. View Article : Google Scholar
|
|
130
|
Yusun A, Wan HM, Chen HX, Sun M, Zhang CN
and Ding XD: Emodin ameliorates dopaminergic neuron loss in the
MPP+ induced Parkinson's disease model: Significant inhibition of
Ferroptosis by activating UQCRC1 protein. Nat Prod Res. 1–12. 2025.
View Article : Google Scholar
|
|
131
|
Lei Y, Zhou J, Xu D, Chai S and Xiong N:
Corilagin attenuates neuronal apoptosis and ferroptosis of
Parkinson's disease through regulating the TLR4/src/NOX2 signaling
pathway. ACS Chem Neurosci. 16:968–980. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Liu X, Zheng Z, Xue C, Wang X, Li J, Liu
Z, Xin W, Xu X, Zhou D, Yao L and Lu G: LRRK2 mediates
α-synuclein-induced neuroinflammation and ferroptosis through the
p62-Keap1-Nrf2 pathway in Parkinson's disease. Inflammation.
48:3666–3691. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Huang L, Pi J, Gu L, Liao Z and Wang W:
Teneligliptin, a DPP4 inhibitor protects dopaminergic neurons in PD
models via inhibiting of oxidative stress and ferroptosis. Eur J
Pharmacol. 1002:1777822025. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
An JR, Su JN, Sun GY, Wang QF, Fan YD,
Jiang N, Yang YF and Shi Y: Liraglutide alleviates cognitive
deficit in db/db mice: Involvement in oxidative stress, iron
overload, and ferroptosis. Neurochem Res. 47:279–294. 2022.
View Article : Google Scholar
|
|
135
|
Chen J, Guo P, Han M, Chen K, Qin J and
Yang F: Cognitive protection of sinomenine in type 2 diabetes
mellitus through regulating the EGF/Nrf2/HO-1 signaling, the
microbiota-gut-brain axis, and hippocampal neuron ferroptosis.
Phytother Res. 37:3323–3341. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Wang B, Zhu S, Guo M, Ma RD, Tang YL, Nie
YX and Gu HF: Artemisinin ameliorates cognitive decline by
inhibiting hippocampal neuronal ferroptosis via Nrf2 activation in
T2DM mice. Mol Med. 30:352024. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Wang Z, Feng S, Li Q, Song Z, He J, Yang
S, Yan C and Ling H: Dihydromyricetin alleviates hippocampal
ferroptosis in type 2 diabetic cognitive impairment rats via
inhibiting the JNK-inflammatory factor pathway. Neurosci Lett.
812:1374042023. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Hu Y, Xu J, Wang J, Wang J, Li Y, Chen W
and Zhang Q: Resveratrol alleviates diabetic adipose Tissue-derived
extracellular vesicles-induced hippocampal ferroptosis and
cognitive dysfunction via inhibiting miR-9-3p/SLC7A11 axis. Mol
Neurobiol. 62:12307–12330. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Chen X, Pang X, Yeo AJ, Xie S, Xiang M,
Shi B, Yu G and Li C: The molecular mechanisms of ferroptosis and
its role in blood-brain barrier dysfunction. Front Cell Neurosci.
16:8897652022. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Wang J, Cao Y, Lu Y, Zhu H, Zhang J, Che
J, Zhuang R and Shao J: Recent progress and applications of small
molecule inhibitors of Keap1-Nrf2 axis for neurodegenerative
diseases. Eur J Med Chem. 264:1159982024. View Article : Google Scholar
|
|
141
|
Liu Q, Zhao Y, Zhou H and Chen C:
Ferroptosis: Challenges and opportunities for nanomaterials in
cancer therapy. Regen Biomater. 10:rbad0042023. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Delila L, Nebie O, Le NTN, Timmerman K,
Lee DY, Wu YW, Chou ML, Buée L, Chou SY, Blum D, et al:
Neuroprotective effects of intranasal extracellular vesicles from
human platelet concentrates supernatants in traumatic brain injury
and Parkinson's disease models. J Biomed Sci. 31:872024. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Liu J, Huang J, Zhang Z, Zhang R, Sun Q,
Zhang Z, Liu Y and Ma B: Mesenchymal stem cell-derived exosomes
ameliorate delayed neurocognitive recovery in aged mice by
inhibiting hippocampus ferroptosis via activating SIRT1/Nrf2/HO-1
signaling pathway. Oxid Med Cell Longev. 2022:35932942022.
View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Xu Y, Jia B, Li J, Li Q and Luo C: The
interplay between ferroptosis and neuroinflammation in central
neurological disorders. Antioxidants (Basel). 13:3952024.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Cai Z, Wang S, Cao S, Chen Y, Penati S,
Peng V, Yuede CM, Beatty WL, Lin K, Zhu Y, et al: Loss of ATG7 in
microglia impairs UPR, triggers ferroptosis, and weakens amyloid
pathology control. J Exp Med. 222:e202301732025. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Li Y, Sun M, Cao F, Chen Y, Zhang L, Li H,
Cao J, Song J, Ma Y, Mi W and Zhang X: The ferroptosis inhibitor
liproxstatin-1 ameliorates LPS-induced cognitive impairment in
mice. Nutrients. 14:45992022. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Long HZ, Cheng Y, Zhou ZW, Luo HY, Wen DD
and Gao LC: The key roles of organelles and ferroptosis in
alzheimer's disease. J Neurosci Res. 100:1257–1280. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Conrad M and Proneth B: Selenium: Tracing
another essential element of ferroptotic cell death. Cell Chem
Biol. 27:409–419. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Kalyanaraman B: NAC, NAC, Knockin' on
Heaven's door: Interpreting the mechanism of action of
N-acetylcysteine in tumor and immune cells. Redox Biol.
57:1024972022. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Xu J, Shen R, Qian M, Zhou Z, Xie B, Jiang
Y, Yu Y and Dong W: Ferroptosis in Alzheimer's disease: The
regulatory role of glial cells. J Integr Neurosci. 24:258452025.
View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Li Y, Zhang E, Yang H, Chen Y, Tao L, Xu
Y, Chen T and Shen X: Gastrodin ameliorates cognitive dysfunction
in vascular dementia rats by suppressing ferroptosis via the
regulation of the Nrf2/Keap1-GPx4 signaling pathway. Molecules.
27:63112022. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Yang L and Nao J: Ferroptosis: A potential
therapeutic target for Alzheimer's disease. Rev Neurosci.
34:573–598. 2023. View Article : Google Scholar
|
|
154
|
Mesa-Herrera F, Marín R, Torrealba E and
Díaz M: Multivariate assessment of lipoxidative metabolites, trace
biometals, and antioxidant and detoxifying activities in the
cerebrospinal fluid define a fingerprint of preclinical stages of
Alzheimer's disease. J Alzheimers Dis. 86:387–402. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Mayr E, Rotter J, Kuhrt H, Winter K,
Stassart RM, Streit WJ and Bechmann I: Detection of molecular
markers of ferroptosis in human Alzheimer's disease brains. J
Alzheimers Dis. 102:1133–1154. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Ayton S, Wang Y, Diouf I, Schneider JA,
Brockman J, Morris MC and Bush AI: Brain iron is associated with
accelerated cognitive decline in people with Alzheimer pathology.
Mol Psychiatry. 25:2932–2941. 2020. View Article : Google Scholar
|
|
157
|
Shi YS, Chen JC, Lin L, Cheng YZ, Zhao Y,
Zhang Y and Pan XD: Dendrobine rescues cognitive dysfunction in
diabetic encephalopathy by inhibiting ferroptosis via activating
Nrf2/GPX4 axis. Phytomedicine. 119:1549932023. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Yang Q, Zhou L, Liu C, Liu D, Zhang Y, Li
C, Shang Y, Wei X, Li C and Wang J: Brain iron deposition in type 2
diabetes mellitus with and without mild cognitive impairment-an in
vivo susceptibility mapping study. Brain Imaging Behav.
12:1479–1487. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Hao L, Mi J, Song L, Guo Y, Li Y, Yin Y
and Zhang C: SLC40A1 mediates ferroptosis and cognitive dysfunction
in type 1 diabetes. Neuroscience. 463:216–226. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Clarke NC, McCabe E, Jensen LD, Creaven BS
and Costello DA: Salicylaldehyde benzoylhydrazone protects against
ferroptosis in models of neurotoxicity and behavioural dysfunction,
in vitro and in vivo. J Mol Neurosci. 75:772025. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Wang Y, Li P, Liang Y and Wang D: ANO6
targets TMEM30A to regulate endoplasmic reticulum Stress-induced
lipid peroxidation and ferroptosis in Alzheimer's cells. Cell
Biochem Biophys. 83:3707–3715. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Lu Z, Jiang Z, Huang X, Chen Y, Feng L,
Mai J, Lao L, Li L, Chen WH and Hu J: Anti-Alzheimer effects of an
HDAC6 inhibitor, WY118, alone and in combination of lithium
chloride: Synergistic suppression of ferroptosis via the modulation
of tau phosphorylation and MAPK signaling. Eur J Pharmacol.
997:1776052025. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Ramesh M and Govindaraju T: MiR-7a-Klf4
axis as a regulator and therapeutic target of neuroinflammation and
ferroptosis in Alzheimer's disease. bioRxiv. Mar 25–2025.Epub ahead
of print. View Article : Google Scholar
|
|
164
|
Zheng N, Zhang Z, Liu H, Zong S, Zhang L,
Cui X, Liu Y, Wang C, Chen R and Lu Z: MK886 ameliorates
Alzheimer's disease by activating the PRKCI/AKT signaling pathway.
Eur J Pharmacol. 993:1773592025. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Feng Y, Wang H, Hu Y, Zhang X, Miao X, Li
Z and Jia J: Hederagenin ameliorates ferroptosis-induced damage by
regulating PPARα/Nrf2/GPX4 signaling pathway in HT22 cells: An in
vitro and in silico study. Bioorg Chem. 155:1081192025. View Article : Google Scholar
|
|
166
|
Tian L, Li H, Xiong W, Li X, Duan S, Yang
C and Shi C: Proteomic alteration in catalpol treatment of
Alzheimer's disease by regulating HSPA5/GPX4. Eur J Pharmacol.
987:1770752025. View Article : Google Scholar
|
|
167
|
Gugliandolo A, Bramanti P and Mazzon E:
Role of vitamin E in the treatment of Alzheimer's disease: Evidence
from animal models. Int J Mol Sci. 18:25042017. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Xiao S, Liu L, Qin X, Xu L, Chai Z and Li
Z: Astragenol alleviates neuroinflammation and improves Parkinson's
symptoms through amino acid metabolism pathway and inhibition of
ferroptosis. J Ethnopharmacol. 348:1198962025. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Wang J, Geng T, Yao X and Liu Y: GDF15
attenuates Parkinson's disease progression via suppressing the
activation of cGAS-STING pathway. Mol Cell Biochem. 480:4449–4466.
2025. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Zhao X, Kang Z, Han R, Wang M, Wang Y, Sun
X, Wang C, Zhou J, Cao L and Lu M: JWA binding to NCOA4 alleviates
degeneration in dopaminergic neurons through suppression of
ferritinophagy in Parkinson's disease. Redox Biol. 73:1031902024.
View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Fu X, Qu L, Xu H and Xie J: Ndfip1
protected dopaminergic neurons via regulating mitochondrial
function and ferroptosis in Parkinson's disease. Exp Neurol.
375:1147242024. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Wang T, Sobue A, Watanabe S, Komine O,
Saido TC, Saito T and Yamanaka K: Dimethyl fumarate improves
cognitive impairment and neuroinflammation in mice with Alzheimer's
disease. J Neuroinflammation. 21:552024. View Article : Google Scholar : PubMed/NCBI
|
